N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
US-2016144047-A1 · May 26, 2016 · US
US9907855B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9907855-B2 |
| Application number | US-201715445381-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 28, 2017 |
| Priority date | Oct 15, 2010 |
| Publication date | Mar 6, 2018 |
| Grant date | Mar 6, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to (among other things) N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides and compositions comprising the same. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
Opening claim text (preview).
What is claimed is: 1. A compound of Formula I-C: wherein: Ar is benzyl, phenyl, naphthyl, biphenyl, or phenanthrenyl; R 1 is methyl, ethyl, n-butyl, i-butyl, or t-butyl; X 1 is a single bond, —O—, —S—, —NH—, or —NHC(O)—; and POLY 1 is a poly(ethylene oxide) oligomer having from 1 to 15 monomers; and pharmaceutically acceptable salts thereof. 2. The compound of claim 1 , according to Formula I-C(R): and pharmaceutically acceptable salts thereof. 3. The compound of claim 1 , according to Formula I-C(S): and pharmaceutically acceptable salts thereof. 4. The compound of claim 1 , wherein POLY 1 is end-capped with hydroxy, methoxy, ethoxy, or benzyloxy. 5. The compound of claim 1 , wherein POLY 1 is end-capped with methoxy. 6. The compound of claim 1 , wherein X 1 is —NHC(O)—. 7. The compound of claim 1 , wherein Ar is phenyl. 8. The compound of claim 1 , wherein R 1 is methyl. 9. The compound of claim 1 , according to formula: wherein n is 1, 2, 3, 4, 5, 6, 7, 8, or 9; and pharmaceutically acceptable salts thereof. 10. A composition comprising a compound of claim 1 and a pharmaceutically acceptable excipient.
with hetero atoms directly attached to ring nitrogen atoms (C07D235/10 takes precedence) · CPC title
Antiepileptics; Anticonvulsants · CPC title
the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol · CPC title
having aromatic rings, e.g. colchicine, atenolol, progabide · CPC title
Human Necessities · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.